drugset / Trial / NCT03973502
Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) With HCV and PD
NaSingle-groupOpen-labelDiagnostic
Summary
The objective of this study is to investigate the evidence of dopaminergic toxicity causing by HCV infection using 18F-FDOPA PET and MRS as imaging biomarkers.
Timeline
- Start
- 2017-06-12
- Primary completion
- 2023-05-31
- Completion
- 2023-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-DOPA | Diagnostic / imaging agent | 185 mbq | Intravenous |